BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8412322)

  • 1. Involvement of the complement system in the pathogenesis of pulmonary leukostasis in experimental myelocytic leukemia.
    van Buchem MA; Levelt CN; Hogendoorn PC; Colly LP; Kluin PM; Willemze R; Daha MR
    Leukemia; 1993 Oct; 7(10):1608-14. PubMed ID: 8412322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pulmonary leukostasis in experimental myelocytic leukemia in the Brown-Norway rat.
    van Buchem MA; Hogendoorn PC; Levelt CN; van Hengel P; Colly LP; Kluin PM; Willemze R
    Leukemia; 1992 Feb; 6(2):142-9. PubMed ID: 1552745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
    Till GO; Morganroth ML; Kunkel R; Ward PA
    Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.
    Ward PA; Till GO; Kunkel R; Beauchamp C
    J Clin Invest; 1983 Sep; 72(3):789-801. PubMed ID: 6886005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis.
    Lester TJ; Johnson JW; Cuttner J
    Am J Med; 1985 Jul; 79(1):43-8. PubMed ID: 3860006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of complement depletion on corneal inflammation in rats.
    Verhagen C; Breebaart AC; Kijlstra A
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):273-9. PubMed ID: 1740355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and neutrophil-mediated injury of perfused rat lungs.
    Morganroth ML; Till GO; Kunkel RG; Ward PA
    Lab Invest; 1986 May; 54(5):507-14. PubMed ID: 3702342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary leukostasis as a first manifestation of an acute myeloid leukemia without hyperleukocitosis].
    Albert-Coll M; Mínguez Gallego C; Burgués Gasión O
    Med Clin (Barc); 2006 Sep; 127(11):437-8. PubMed ID: 17020692
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement dependence of antibody-induced mesangial cell injury in the rat.
    Yamamoto T; Wilson CB
    J Immunol; 1987 Jun; 138(11):3758-65. PubMed ID: 3495569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial activation antigens in pulmonary leukostasis in leukemia.
    van Buchem MA; Hogendoorn PC; Bruijn JA; Kluin PM
    Acta Haematol; 1993; 90(1):29-33. PubMed ID: 8237271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental myelocytic leukemia in the Brown-Norway rat as a model for pulmonary leukostasis.
    van Buchem MA; Colly LP; Hogendoorn PC; Kluin PM; Willemze R
    Am J Pathol; 1991 Mar; 138(3):777-80. PubMed ID: 2000946
    [No Abstract]   [Full Text] [Related]  

  • 12. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
    Vogel CW; Fritzinger DC
    Curr Pharm Des; 2007; 13(28):2916-26. PubMed ID: 17979736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
    Mulligan MS; Yeh CG; Rudolph AR; Ward PA
    J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal sonicate-induced biphasic granulocytopenia and its dissociation from pulmonary leukostasis. The contribution of pneumococcal products and complement to early and late granulocytopenic phases.
    Goldblum SE; Reed WP; Thilsted JP
    J Lab Clin Med; 1983 Dec; 102(6):987-99. PubMed ID: 6644159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of complement in endotoxin/platelet-activating factor-induced lung injury.
    Rabinovici R; Yeh CG; Hillegass LM; Griswold DE; DiMartino MJ; Vernick J; Fong KL; Feuerstein G
    J Immunol; 1992 Sep; 149(5):1744-50. PubMed ID: 1324280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of glucocorticoids in a complement-activated state induced by cobra venom factor in rats.
    Nakano K; Suzuki S; Chanho O; Yamashita K
    Acta Endocrinol (Copenh); 1986 May; 112(1):122-9. PubMed ID: 3716753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of total hemolytic complement activity with Naja haje cobra venom factor does not prevent endotoxin-induced lung injury in sheep.
    Flick MR; Horn JK; Hoeffel JM; Goldstein IM
    Am Rev Respir Dis; 1986 Jan; 133(1):62-7. PubMed ID: 3510582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.
    Larsen GL; Webster RO; Worthen GS; Gumbay RS; Henson PM
    J Clin Invest; 1985 Mar; 75(3):902-10. PubMed ID: 3980730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs.
    Pleyer U; Mondino BJ; Sumner HL
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2212-5. PubMed ID: 1607231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key role of complement activation and platelet-activating factor in exudate formation in zymosan-induced rat pleurisy.
    Imai Y; Hayashi M; Oh-ishi S
    Jpn J Pharmacol; 1991 Oct; 57(2):225-32. PubMed ID: 1812301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.